Hideki Kazuno - Concepedia

Author

Hideki Kazuno

Taiho Pharmaceutical (Japan)

Also Known As

H Kazuno, H. KAZUNO, H. Kazuno, Hideki KAZUNO, Hideki Kazuno

Publications

535

Citations

H-Index

Concepts

All Affiliations

Taiho Pharmaceutical (Japan)

About

Hideki Kazuno is an author at Taiho Pharmaceutical (Japan) specializing in biochemistry, chemical biology, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	4	4	418
2	Medicine	3	3	182
3	Natural Sciences	3	3	319
4	Chemical Biology	3	3	319
5	Cell Biology	1	1	99

Hideki Kazuno

Publications

518

Citations

H-Index

Page 1

	Year	Citations
Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2′-deoxyribonucleosides Masakazu Fukushima, Norihiko Suzuki, Tomohiro Emura, Biochemical Pharmacology Specific InhibitorsMedicinal ChemistryAntitumor 2′-DeoxyribonucleosidesBiochemistryNatural Sciences	2000	236
Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. Yuko Murakami, Hideki Kazuno, Tomohiro Emura, International Journal of Oncology Tumor BiologyDifferent MechanismsOncologyBiochemistryPyrimidine Metabolism	2000	99
Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 2: Optimization of inhibitors of human thymidine phosphorylase and their selectivity with uridine phosphorylase Shingo Yano, Hideki Kazuno, Tsutomu Sato, Bioorganic & Medicinal Chemistry Medicinal ChemistryDerivative (Chemistry)BiochemistryNatural SciencesMedicine	2004	53
The Novel VEGF Receptor/MET–Targeted Kinase Inhibitor TAS-115 Has Marked <i>In Vivo</i> Antitumor Properties and a Favorable Tolerability Profile Hidenori Fujita, Kazutaka Miyadera, Masanori Kato, Molecular Cancer Therapeutics	2013	37
The first total synthesis of tetronasin (M139603) Kozo Hori, Hideki Kazuno, Keiichi Nomura, Tetrahedron Letters First Total SynthesisSynthesis MethodChemistry	1993	32
Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use Satoru Ito, Sachie Otsuki, Hirokazu Ohsawa, ACS Medicinal Chemistry Letters	2023	31
Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 1: Discovery of novel orally active inhibitors of human thymidine phosphorylase Shingo Yano, Hideki Kazuno, Norihiko Suzuki, Bioorganic & Medicinal Chemistry Medicinal ChemistryDerivative (Chemistry)BiochemistryNatural SciencesActive Inhibitors	2004	30

Page 1